Table 1 Baseline characteristics of study population
|  | AIH (n = 160) | PBC (n = 37) | PSC (n = 20) | Overlap syndrome (n = 48) |
|---|---|---|---|---|
Age, yrs, mean (SD) | 46.4 (14.0) | 51.2 (12.7) | 39.7 (9.5) | 43.1 (13.2) |
BMI, kg/m2, mean (SD) | 25.9 (3.9) | 27.1 (4.2) | 24.2 (3.9) | 24.1(3.8) |
Sex, women, No. (%) | 114 (71.2) | 31 (83.8) | 11 (55.0) | 32 (66.7) |
First presentation, yes, No. (%) | Â | Â | Â | Â |
 Non-specific symptoms | 40 (25.0%) | 20 (54.1) | 8 (40.0) | 22 (45.8) |
 Asymptomatic | 20 (12.5) | 5 (13.5) | 6 (30.0) | 9 (18.8) |
 Acute hepatitis | 58 (36.2) | 7 (18.9) | 2 (10.0) | 10 (20.8) |
 Cirrhosis | 52 (32.5) | 6 (16.2) | 5 (25.0) | 9 (18.8) |
Common comorbidities, yes, No. (%) | Â | Â | Â | Â |
 Hypothyroidism | 8 (5.0%) | 2 (5.4%) | 0 (0.0%) | 1 (2.1%) |
 Crohn’s disease | 1 (0.06%) | 1 (2.7%) | 0 (0.0%) | 0 (0.0%) |
 SLE | 2 (1.2%) | 0 (0.0%) | 0 (0.0%) | 2 (4.2%) |
 UC | 2 (1.2%) | 0 (0.0%) | 8 (40.0%) | 5 (10.4%) |
 RA | 7 (4.4%) | 1 (2.7%) | 2 (10.0%) | 0 (0.0%) |